Indeed, many patients undergo biopsy for elevated serum PSA with no other clinical evidence of cancer, resulting in an enormous number of biopsies performed even if numerous diagnostic pitfalls (e.g., fatigue, time-consuming workflow) and mimics of prostate cancer have been described. The gene discussed is KLK3; the disease is prostate carcinoma.